FDA Panel Votes 17-6 Obesity Drugmakers Should Study Heart Risks; Watch Orexigen (OREX, VIVUS (VVUS), Arena (ARNA)

Go back to FDA Panel Votes 17-6 Obesity Drugmakers Should Study Heart Risks; Watch Orexigen (OREX, VIVUS (VVUS), Arena (ARNA)